[ASCO guideline for the management of stage III NSCLC part 3: indications for neoadjuvant therapy]
- PMID: 35181797
- DOI: 10.1007/s00104-022-01602-1
[ASCO guideline for the management of stage III NSCLC part 3: indications for neoadjuvant therapy]
Comment on
-
Management of Stage III Non-Small-Cell Lung Cancer: ASCO Guideline.J Clin Oncol. 2022 Apr 20;40(12):1356-1384. doi: 10.1200/JCO.21.02528. Epub 2021 Dec 22. J Clin Oncol. 2022. PMID: 34936470 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
